Randomised Clinical Trial: 48 Weeks of Treatment with Tenofovir Amibufenamide Versus Tenofovir Disoproxil Fumarate for Patients with Chronic Hepatitis B.
Alimentary pharmacology & therapeutics（2021）
摘要
Tenofovir amibufenamide (TMF) can provide more efficient delivery than tenofovir disoproxil fumarate (TDF).
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要